BG103986A - Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists - Google Patents

Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists

Info

Publication number
BG103986A
BG103986A BG103986A BG10398699A BG103986A BG 103986 A BG103986 A BG 103986A BG 103986 A BG103986 A BG 103986A BG 10398699 A BG10398699 A BG 10398699A BG 103986 A BG103986 A BG 103986A
Authority
BG
Bulgaria
Prior art keywords
derivatives
endotheline
endotheline antagonists
pyrrolidinecarboxylic acids
pyrrolidinecarboxylic
Prior art date
Application number
BG103986A
Other languages
Bulgarian (bg)
Inventor
Andrew Tasker
Martin Winn
Steven Boyd
Hwan-Soo Jae
GELDERN Thomas VON
Bryan SORENSEN
Kenneth HENRY
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG103986A publication Critical patent/BG103986A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to a compound with the formula or to its pharmaceutically acceptable salt, as well as methods and intermediate compounds for its preparation. It also relates to a method for endotheline antagonization. 36 claims
BG103986A 1997-06-17 1999-12-10 Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists BG103986A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87718797A 1997-06-17 1997-06-17
PCT/US1998/011821 WO1998057933A1 (en) 1997-06-17 1998-06-08 Pyrrolidine carboxylic acid derivatives as endothelin antagonists

Publications (1)

Publication Number Publication Date
BG103986A true BG103986A (en) 2000-08-31

Family

ID=25369437

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103986A BG103986A (en) 1997-06-17 1999-12-10 Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists

Country Status (8)

Country Link
AR (1) AR016071A1 (en)
AU (1) AU7826398A (en)
BG (1) BG103986A (en)
HU (1) HUP0002681A3 (en)
NO (1) NO996244L (en)
PL (1) PL348667A1 (en)
WO (1) WO1998057933A1 (en)
ZA (1) ZA985209B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
CA2386190C (en) 1999-10-13 2009-04-14 Johns Hopkins University School Of Medicine Regulators of the hedgehog pathway, compositions and uses related thereto
US6552016B1 (en) 1999-10-14 2003-04-22 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
ATE324876T1 (en) * 1999-10-14 2006-06-15 Curis Inc AGENTS OF ßHEDGEHOGß TRANSMITTING RAILWAYS, ASSOCIATED INTERLINGS AND USE
AR044510A1 (en) * 2003-04-14 2005-09-14 Merck & Co Inc PROCEDURE AND INTERMEDIATES TO PREPARE CARBOXILIC ACIDS OF PIRROLIDINE
CN114507143A (en) * 2022-02-26 2022-05-17 江苏壹药新材料有限公司 Synthesis method of 2-ethyl-1-fluoro-4-nitrobenzene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006095A1 (en) * 1994-08-19 1996-02-29 Abbott Laboratories Endothelin antagonists
JP2000504727A (en) * 1996-02-13 2000-04-18 アボット・ラボラトリーズ 4- (benzo-1,3-dioxolyl) -pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists

Also Published As

Publication number Publication date
WO1998057933A1 (en) 1998-12-23
AR016071A1 (en) 2001-06-20
HUP0002681A3 (en) 2001-09-28
HUP0002681A2 (en) 2001-08-28
NO996244L (en) 2000-01-12
ZA985209B (en) 1999-01-06
PL348667A1 (en) 2002-06-03
AU7826398A (en) 1999-01-04
NO996244D0 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG103882A (en) Voriconazol-containing pharmaceutical compositions
CA2195677A1 (en) Endothelin antagonists
DE69705829D1 (en) META-SUBSTITUTED PHENYLSULPHONAMIDE DERIVATIVES
ES2158537T3 (en) DERIVATIVES OF CYCLOPROPILALCANOIC ACIDS.
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
WO2001064645A3 (en) Derivatives of quinoline as alpha-2 antagonists
AU6518998A (en) Morphinane derivatives and medicinal use thereof
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
BG103863A (en) Indazolamide compounds as serotoninergic forms
DK1302207T3 (en) Process for preparing an antihypertensive agent containing a dipeptide as an effective ingredient
WO1999006397A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
BG105197A (en) Polymorph form of a medicament
BG102589A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
BG104447A (en) Biphenylamidine derivatives
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
PL353875A1 (en) Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
TW280819B (en)
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
EP1043311A4 (en) Biphenylamidine derivatives
EP1008345A4 (en) Antiallergic agents